Skip to main content
Log in

Trazodone in late life depressive states: a double-blind multicenter study versus amitriptyline and mianserin

  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Seventy five elderly depressed in-patients, ages ranging from 60 to 83 years, diagnosed as Major Depression according to DSM III were treated, under double-blind conditions, with 75 mg Amitriptyline (AMI) (26 patients), 60 mg Mianserin (MIA) (24 patients) or 150 mg Trazodone (TRZ) (25 patients) p.o. for 5 weeks. There were no differences in the clinical outcome between the three groups of patients at the end of the trial, with a significant amelioration (P<0.01) at the Hamilton Rating Scale for Depression and Geriatric Depression Scale. TRZ showed a significantly lower incidence of side effects compared to MIA and AMI. Atypical antidepressants, including TRZ, seem more suitable for treating elderly depression than the first generation antidepressants on the basis of risk/benefit ratio considerations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Altamura AC (1987) Anxious-depressive syndromes in the elderly: assessment, clinical course and treatment. In: Racagni G, Smeraldi E (eds) Anxious depression: assessment and treatment. Raven Press, New York, pp 209–216

    Google Scholar 

  • Altamura AC, Melorio T, Invernizzi G, Gomeni R (1982) Influence of age on mianserin pharmacokinetics. Psychopharmacology 78:380–382

    Google Scholar 

  • Altamura AC, Melorio T, Invernizzi G, Colacurcio F, Gomeni R (1983) Age related differences in kinetics and side-effects of viloxazine in man and their clinical implications. Psychopharmacology 81:281–285

    Google Scholar 

  • Altamura AC, Mauri MC, Guercetti G (1986) Age, therapeutic “milieu” and clinical outcome in depressive patients treated with viloxazine: a study with plasma levels. Prog Neuropsychopharmacol Biol Psychiatry 10:67–75

    Google Scholar 

  • Bayer AJ, Pathy MSJ, Ankier SI (1983) Pharmacokinetic and pharmacodynamic characteristics of trazodone in the elderly. Br J Clin Pharmacol 16:371–376

    Google Scholar 

  • Brink TL, Yesavage JA, Lum O, Heersema PH, Adey M, Rose TL (1982) Screening tests for geriatric depression. Clin Gerontol 1(1)37–43

    Google Scholar 

  • Burns M, Moskowitz H, Jaffe J (1986) A comparison of the effects of trazodone and amitriptyline on skills performance by geriatric subjects. J Clin Psychiatry 47, 5:252–256

    Google Scholar 

  • Cazzullo CL, Altamura AC (1985) Bioavailability of some atypical antidepressants and therapeutic management of late life depressive states. Integr Psychiatry 3, 50 S–56 S

  • Fassler RB, Gaviria M (1978) Depression in old age. J Am Geriatr Soc 26:471–475

    Google Scholar 

  • Frederich CT (1978) Current trends in suicidal behaviour in the United States. Am J Psychother 32:172–200

    Google Scholar 

  • Gershon S (1984) Comparative side-effect profiles of trazodone and imipramine: special reference to a geriatric population. Psychopathology 17(2):39–50

    Google Scholar 

  • Gottfries CG (1981) Treatment of depression in the elderly. General clinical considerations. Acta Psychiatr Scand 290 (S 63):401–409

    Google Scholar 

  • Gram LF, Reisby N, Bech P, Nagy A, Christiansen J (1978) Factors influencing pharmacokinetics and clinical effects of tricyclic antidepressants. In: Garattini S (ed) Depressive disorders. Schattauer, Stuttgart New York, pp 337–346

    Google Scholar 

  • Grimmson A, Idanpaan-Heikkila J, Lunde PK, Olafsson O, Westerhol MM (1977) Ferbrukninger aw psykofarmaka i Finland, Island Norge, och Sverige. Nord Med 92:49–54

    Google Scholar 

  • Guy W (1976) ECDEU assessment manual for psychopharmacology. DHEW Publication No. 76-338, Washington, D.C.

  • Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62

    CAS  PubMed  Google Scholar 

  • Montgomery SA (1982) Treatment of depression in old age. In: Wheatley D (ed) Psychopharmacology of old age. University Press, Oxford, pp 165–172

    Google Scholar 

  • Murphy E (1983) The prognosis of depression in old age. Br J Psychiatry 142:111–119

    Google Scholar 

  • Robinson DS (1983) Aging and neuropsychopharmacology. In: Yetiv JZ, Bianchine JR (eds) Recent advances in clinical therapeutics. Grune & Stratton, New York, pp 127–157

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Altamura, A.C., Mauri, M.C., Colacurcio, F. et al. Trazodone in late life depressive states: a double-blind multicenter study versus amitriptyline and mianserin. Psychopharmacology 95, S34–S36 (1988). https://doi.org/10.1007/BF00172628

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00172628

Key words

Navigation